ALNYLAM PHARMACEUTICALS, INC. Quarterly Operating Margin in % from Q4 2021 to Q4 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Alnylam Pharmaceuticals, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q4 2022.
  • Alnylam Pharmaceuticals, Inc. Operating Margin for the quarter ending December 31, 2022 was -75.7 %, a 9.84% increase year-over-year.
  • Alnylam Pharmaceuticals, Inc. annual Operating Margin for 2022 was -75.7 %, a 9.84% increase from 2021.
  • Alnylam Pharmaceuticals, Inc. annual Operating Margin for 2021 was -83.9 %, a 50.1% increase from 2020.
  • Alnylam Pharmaceuticals, Inc. annual Operating Margin for 2020 was -168 %, a 60.7% increase from 2019.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -75.7 +8.26 +9.84% Oct 1, 2022 Dec 31, 2022
Q3 2022 -82.3 Jul 1, 2022 Sep 30, 2022
Q2 2022 -80.8 Apr 1, 2022 Jun 30, 2022
Q1 2022 -76 Jan 1, 2022 Mar 31, 2022
Q4 2021 -83.9 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.